Taguchi et al [16] reported a matrix-assisted laser desorption ionization (MALDI) mass spectrometry (MS) algorithm that could classify NSCLC patients with good or poor outcomes after treatment with EGFR TKIs. Here, EGFR is linked to non-small cell lung carcinoma.